Related Experiment Video
Updated: Jun 2, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Chemotherapy-induced cardiomyopathy
Syed Wamique Yusuf1, Nasreen A Ilias-Khan, Jean-Bernard Durand
1University of Texas MD Anderson Cancer Center, Department of Cardiology, 1515 Holcombe Blvd, Unit 1451, Houston, TX 77030, USA. syusuf@mdanderson.org
Abstract:
Improvement in cancer therapy has led to an increasing number of cancer survivors, some of whom may suffer from the cardiotoxic effects of chemotherapy. Cardiomyopathy can occur years after completion of the chemotherapy and it is important to recognize this early, as complete recovery of cardiac function is possible in some cases. In this article we will review chemotherapy-induced cardiomyopathy and discuss its treatment options.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis I: Introduction
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
